We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00445926
Recruitment Status : Completed
First Posted : March 9, 2007
Last Update Posted : May 6, 2010
Sponsor:
Information provided by:
Shalvata Mental Health Center

Brief Summary:
The study evaluates the feasibility of using a 4 week stimulation protocol with the deep TMS H-coils for the treatment of negative symptoms and cognitive deficit in schizophrenia patients

Condition or disease Intervention/treatment Phase
Schizophrenia Device: deep TMS H-coil Phase 1

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Deep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia
Study Start Date : July 2006
Primary Completion Date : May 2009
Study Completion Date : May 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM IV Diagnosis of Schizophrenia
  • PANNS Negative > 21

Exclusion Criteria:

  • risk factors for convulsions
  • PANNS positive > 24

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00445926


Locations
Israel
Shalvata MHC
Hod Hasharon, Israel
Sponsors and Collaborators
Shalvata Mental Health Center
Investigators
Principal Investigator: Eiran V Harel, MD Shalvata MHC

Responsible Party: Hilik Levkovitz, shalvataMHC
ClinicalTrials.gov Identifier: NCT00445926     History of Changes
Other Study ID Numbers: SH-40206
First Posted: March 9, 2007    Key Record Dates
Last Update Posted: May 6, 2010
Last Verified: May 2010

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders